BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 6883282)

  • 1. Effect of timing and sequence of hyperthermia and cyclophosphamide on a neurogenic rat tumor (BT4A) in vivo.
    Dahl O; Mella O
    Cancer; 1983 Sep; 52(6):983-7. PubMed ID: 6883282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hyperthermia on a neurogenic rat cell line (BT4A) in vivo.
    Dahl O
    Acta Radiol Oncol; 1982; 21(1):67-77. PubMed ID: 6283799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperthermic potentiation of doxorubicin and 4'-epi-doxorubicin in a transplantable neurogenic rat tumor (BT4A) in BD IX rats.
    Dahl O
    Int J Radiat Oncol Biol Phys; 1983 Feb; 9(2):203-7. PubMed ID: 6572622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced effect of combined hyperthermia and chemotherapy (bleomycin, BCNU) in a neurogenic rat tumour (BT4A) in vivo.
    Dahl O; Mella O
    Anticancer Res; 1982; 2(6):359-64. PubMed ID: 6188410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Timing of combined hyperthermia and 1,3-bis(2-chloroethyl)-1-nitrosourea or cis-diamminedichloroplatinum in BD IX rats with BT4A tumours.
    Mella O; Dahl O
    Anticancer Res; 1985; 5(3):259-63. PubMed ID: 4040349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors.
    Willerding L; Limmer S; Hossann M; Zengerle A; Wachholz K; Ten Hagen TL; Koning GA; Sroka R; Lindner LH; Peller M
    J Control Release; 2016 Jan; 222():47-55. PubMed ID: 26658073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperthermia or BCNU alone and combined in BD IX rats with BT4An tumours. Effects of a single or two equal fractions at different intervals.
    Mella O
    In Vivo; 1988; 2(5):307-12. PubMed ID: 2979849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the vasodilator sodium nitroprusside during local hyperthermia: effects on tumor temperature and tumor response in a rat tumor model.
    Krossnes BK; Mella O; Dahl O
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):403-15. PubMed ID: 8892466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
    Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
    Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of cyclophosphamide on the growth and cellular kinetics of a transplantable rat fibrosarcoma.
    Peel S; Cowen DM
    Br J Cancer; 1972 Aug; 26(4):304-14. PubMed ID: 5071192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumour.
    Borkamo ED; Fluge O; Mella O; Akslen LA; Bruland O; Dahl O
    Radiother Oncol; 2008 Mar; 86(3):435-42. PubMed ID: 18313158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hyperglycemia on thermochemotherapy of a spontaneous murine fibrosarcoma.
    Urano M; Kim MS
    Cancer Res; 1983 Jul; 43(7):3041-4. PubMed ID: 6850614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined hyperthermia and cis-diamminedichloroplatinum in BD IX rats with transplanted BT4A tumours.
    Mella O
    Int J Hyperthermia; 1985; 1(2):171-83. PubMed ID: 3837668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement by hyperthermia of the effect of BCNU against the EMT6 mouse tumor.
    Twentyman PR; Morgan JE; Donaldson J
    Cancer Treat Rep; 1978 Mar; 62(3):439-43. PubMed ID: 647699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solid tumor models for the assessment of different treatment modalities. XXI. Comparison of different radiation dose schedules alone or in combination with cyclophosphamide.
    Looney WB; Longerbeam MB; Hopkins HA; Carter WH
    Cancer; 1983 Mar; 51(6):1012-20. PubMed ID: 6821865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasonic hyperthermia and drugs as therapy for human tumor xenografts.
    Senapati N; Houchens D; Ovejera A; Beard R; Nines R
    Cancer Treat Rep; 1982 Aug; 66(8):1635-9. PubMed ID: 7105053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local hyperthermia in treatment of experimental liver tumors.
    Hugander A; Hafström L; Jönsson PE; Bolmsjö M; Persson BR; Stenram U
    Cancer; 1984 Apr; 53(8):1686-91. PubMed ID: 6697305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing mice.
    Hengst JC; Mokyr MB; Dray S
    Cancer Res; 1980 Jul; 40(7):2135-41. PubMed ID: 6446379
    [No Abstract]   [Full Text] [Related]  

  • 20. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. I. Variation in administration of both agents.
    Fisher B; Wolmark N; Rubin H; Saffer E
    J Natl Cancer Inst; 1975 Nov; 55(5):1147-53. PubMed ID: 1206740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.